Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Valliant Insider Profile
4 Followers
John Valliant, CEO, Director at Fusion Pharmaceuticals, holds 0.00 shares in Fusion Pharmaceuticals (Ticker: FUSN).
John Valliant Fusion Pharmaceuticals (FUSN)CEO, Director
Fusion Pharmaceuticals (FUSN)
CEO, Director
Not Ranked
John Valliant has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
John Valliant does not currently own shares as a corporate insider.
A breakdown of John Valliant's holdings
Insider Roles
John Valliant does not currently hold a role as a corporate insider.
Roles that John Valliant holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Valliant
John Valliant's Trading History
List of latest transactions for each holding click on a transaction to see John Valliant's performance on stock
You May Also Like
John Valliant insider profile FAQ
What is the percentage of profitable transactions made by John Valliant?
The percentage of profitable transactions made by John Valliant is ―.
What is the average return per transaction made by John Valliant?
The average return per transaction made by John Valliant is ―.
What stocks does John Valliant hold?
John Valliant holds: FUSN stocks.
What was John Valliant’s latest transaction?
John Valliant latest transaction was an Uninformative Sell of ―.
What was John Valliant's most profitable transaction?
John Valliant’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Valliant's role in Fusion Pharmaceuticals?
John Valliant's role in Fusion Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.